Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients

Andrea Corsonello, Claudio Pedone, Marco Pahor, Alba Malara, Luciana Carosella, Bruno Mazzei, Graziano Onder, Francesco Corsonello, Pierugo Carbonin, Francesco Corica

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We performed this cross-sectional case control study to investigate the association between low serum magnesium levels and cognitive impairment in hypertensive hospitalized patients. The study was carried oui in general medical care units at 81 hospitals participating in the Gruppo Ilaliano di Farmacovigilanza nell'Anziano (GIFA) study throughout Italy, and a total of 1058 patients with diagnoses of hypertension at the discharge were studied. The occurrence of cognitive impairment at discharge was the primary outcome of our study. Cognitive impairment was ascertained using the Hodkinson Abbreviated Mental Test (HAMT). Sociodemographic variables, body mass index, laboratory parameters, comorbidity, use of antihypertensive drugs and number of drugs were considered as potential confounders. Twenty-nine per cent of the selected hypertensive patients were classified as having cognitive impairment. In univariate analysis, older age, female sex, and low educational level showed a significant trend for association to cognitive impairment. Moreover, the proportion of subjects with cognitive impairment decreased with increasing alcohol consumption, and the prevalence of ex smokers and smokers was significantly lower in patients with cognitive impairment. The lower tertiles for serum albumin and creatinine clearance were more frequent among patients with cognitive impairment, and the lower tertile for serum magnesium levels was significantly more frequent in these patients. Number of drugs was slightly lower in cognitively impaired patients, while number of diagnoses and length of hospital stay were higher in these subjects. In the multivariate logistic regression analysis cognitive impairment decreased with increasing education level (highest education: OR 0.11: 95 per cent CI 0.05-0.25). The lower tertile for serum albumin (<3.5 g/dl) was significantly associated to cognitive impairment (OR 2.14: 95 per cent CI 1.31-3.49). as well as the lower tertiles for serum magnesium (0.74-0.86 mmol/L: OR 1.54: 95 per cent CI 1.06-2.22; <0.74 mmol/L: OR 1.75; 95 per cent CI 1.13-2.72). Our results demonstrate the existence of a significant association between magnesium imbalance and cognitive impairment. These data suggest that the assessment of magnesium status may be of some relevance in hypertensive subjects with cognitive disorders.

Original languageEnglish
Pages (from-to)273-282
Number of pages10
JournalMagnesium Research
Volume14
Issue number4
Publication statusPublished - 2001

Fingerprint

Magnesium
Serum
Serum Albumin
Education
Health care
Regression analysis
Pharmaceutical Preparations
Antihypertensive Agents
Logistics
Creatinine
Length of Stay
Alcohols
Cognitive Dysfunction
Intelligence Tests
Alcohol Drinking
Italy
Case-Control Studies
Comorbidity
Body Mass Index
Logistic Models

Keywords

  • Cognitive impairment
  • Elderly
  • Hypertension
  • Serum magnesium

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Corsonello, A., Pedone, C., Pahor, M., Malara, A., Carosella, L., Mazzei, B., ... Corica, F. (2001). Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients. Magnesium Research, 14(4), 273-282.

Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients. / Corsonello, Andrea; Pedone, Claudio; Pahor, Marco; Malara, Alba; Carosella, Luciana; Mazzei, Bruno; Onder, Graziano; Corsonello, Francesco; Carbonin, Pierugo; Corica, Francesco.

In: Magnesium Research, Vol. 14, No. 4, 2001, p. 273-282.

Research output: Contribution to journalArticle

Corsonello, A, Pedone, C, Pahor, M, Malara, A, Carosella, L, Mazzei, B, Onder, G, Corsonello, F, Carbonin, P & Corica, F 2001, 'Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients', Magnesium Research, vol. 14, no. 4, pp. 273-282.
Corsonello, Andrea ; Pedone, Claudio ; Pahor, Marco ; Malara, Alba ; Carosella, Luciana ; Mazzei, Bruno ; Onder, Graziano ; Corsonello, Francesco ; Carbonin, Pierugo ; Corica, Francesco. / Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients. In: Magnesium Research. 2001 ; Vol. 14, No. 4. pp. 273-282.
@article{6682637e299644a48bc8587bbd3e0b08,
title = "Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients",
abstract = "We performed this cross-sectional case control study to investigate the association between low serum magnesium levels and cognitive impairment in hypertensive hospitalized patients. The study was carried oui in general medical care units at 81 hospitals participating in the Gruppo Ilaliano di Farmacovigilanza nell'Anziano (GIFA) study throughout Italy, and a total of 1058 patients with diagnoses of hypertension at the discharge were studied. The occurrence of cognitive impairment at discharge was the primary outcome of our study. Cognitive impairment was ascertained using the Hodkinson Abbreviated Mental Test (HAMT). Sociodemographic variables, body mass index, laboratory parameters, comorbidity, use of antihypertensive drugs and number of drugs were considered as potential confounders. Twenty-nine per cent of the selected hypertensive patients were classified as having cognitive impairment. In univariate analysis, older age, female sex, and low educational level showed a significant trend for association to cognitive impairment. Moreover, the proportion of subjects with cognitive impairment decreased with increasing alcohol consumption, and the prevalence of ex smokers and smokers was significantly lower in patients with cognitive impairment. The lower tertiles for serum albumin and creatinine clearance were more frequent among patients with cognitive impairment, and the lower tertile for serum magnesium levels was significantly more frequent in these patients. Number of drugs was slightly lower in cognitively impaired patients, while number of diagnoses and length of hospital stay were higher in these subjects. In the multivariate logistic regression analysis cognitive impairment decreased with increasing education level (highest education: OR 0.11: 95 per cent CI 0.05-0.25). The lower tertile for serum albumin (<3.5 g/dl) was significantly associated to cognitive impairment (OR 2.14: 95 per cent CI 1.31-3.49). as well as the lower tertiles for serum magnesium (0.74-0.86 mmol/L: OR 1.54: 95 per cent CI 1.06-2.22; <0.74 mmol/L: OR 1.75; 95 per cent CI 1.13-2.72). Our results demonstrate the existence of a significant association between magnesium imbalance and cognitive impairment. These data suggest that the assessment of magnesium status may be of some relevance in hypertensive subjects with cognitive disorders.",
keywords = "Cognitive impairment, Elderly, Hypertension, Serum magnesium",
author = "Andrea Corsonello and Claudio Pedone and Marco Pahor and Alba Malara and Luciana Carosella and Bruno Mazzei and Graziano Onder and Francesco Corsonello and Pierugo Carbonin and Francesco Corica",
year = "2001",
language = "English",
volume = "14",
pages = "273--282",
journal = "Magnesium Research",
issn = "0953-1424",
publisher = "John Libbey Eurotext",
number = "4",

}

TY - JOUR

T1 - Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients

AU - Corsonello, Andrea

AU - Pedone, Claudio

AU - Pahor, Marco

AU - Malara, Alba

AU - Carosella, Luciana

AU - Mazzei, Bruno

AU - Onder, Graziano

AU - Corsonello, Francesco

AU - Carbonin, Pierugo

AU - Corica, Francesco

PY - 2001

Y1 - 2001

N2 - We performed this cross-sectional case control study to investigate the association between low serum magnesium levels and cognitive impairment in hypertensive hospitalized patients. The study was carried oui in general medical care units at 81 hospitals participating in the Gruppo Ilaliano di Farmacovigilanza nell'Anziano (GIFA) study throughout Italy, and a total of 1058 patients with diagnoses of hypertension at the discharge were studied. The occurrence of cognitive impairment at discharge was the primary outcome of our study. Cognitive impairment was ascertained using the Hodkinson Abbreviated Mental Test (HAMT). Sociodemographic variables, body mass index, laboratory parameters, comorbidity, use of antihypertensive drugs and number of drugs were considered as potential confounders. Twenty-nine per cent of the selected hypertensive patients were classified as having cognitive impairment. In univariate analysis, older age, female sex, and low educational level showed a significant trend for association to cognitive impairment. Moreover, the proportion of subjects with cognitive impairment decreased with increasing alcohol consumption, and the prevalence of ex smokers and smokers was significantly lower in patients with cognitive impairment. The lower tertiles for serum albumin and creatinine clearance were more frequent among patients with cognitive impairment, and the lower tertile for serum magnesium levels was significantly more frequent in these patients. Number of drugs was slightly lower in cognitively impaired patients, while number of diagnoses and length of hospital stay were higher in these subjects. In the multivariate logistic regression analysis cognitive impairment decreased with increasing education level (highest education: OR 0.11: 95 per cent CI 0.05-0.25). The lower tertile for serum albumin (<3.5 g/dl) was significantly associated to cognitive impairment (OR 2.14: 95 per cent CI 1.31-3.49). as well as the lower tertiles for serum magnesium (0.74-0.86 mmol/L: OR 1.54: 95 per cent CI 1.06-2.22; <0.74 mmol/L: OR 1.75; 95 per cent CI 1.13-2.72). Our results demonstrate the existence of a significant association between magnesium imbalance and cognitive impairment. These data suggest that the assessment of magnesium status may be of some relevance in hypertensive subjects with cognitive disorders.

AB - We performed this cross-sectional case control study to investigate the association between low serum magnesium levels and cognitive impairment in hypertensive hospitalized patients. The study was carried oui in general medical care units at 81 hospitals participating in the Gruppo Ilaliano di Farmacovigilanza nell'Anziano (GIFA) study throughout Italy, and a total of 1058 patients with diagnoses of hypertension at the discharge were studied. The occurrence of cognitive impairment at discharge was the primary outcome of our study. Cognitive impairment was ascertained using the Hodkinson Abbreviated Mental Test (HAMT). Sociodemographic variables, body mass index, laboratory parameters, comorbidity, use of antihypertensive drugs and number of drugs were considered as potential confounders. Twenty-nine per cent of the selected hypertensive patients were classified as having cognitive impairment. In univariate analysis, older age, female sex, and low educational level showed a significant trend for association to cognitive impairment. Moreover, the proportion of subjects with cognitive impairment decreased with increasing alcohol consumption, and the prevalence of ex smokers and smokers was significantly lower in patients with cognitive impairment. The lower tertiles for serum albumin and creatinine clearance were more frequent among patients with cognitive impairment, and the lower tertile for serum magnesium levels was significantly more frequent in these patients. Number of drugs was slightly lower in cognitively impaired patients, while number of diagnoses and length of hospital stay were higher in these subjects. In the multivariate logistic regression analysis cognitive impairment decreased with increasing education level (highest education: OR 0.11: 95 per cent CI 0.05-0.25). The lower tertile for serum albumin (<3.5 g/dl) was significantly associated to cognitive impairment (OR 2.14: 95 per cent CI 1.31-3.49). as well as the lower tertiles for serum magnesium (0.74-0.86 mmol/L: OR 1.54: 95 per cent CI 1.06-2.22; <0.74 mmol/L: OR 1.75; 95 per cent CI 1.13-2.72). Our results demonstrate the existence of a significant association between magnesium imbalance and cognitive impairment. These data suggest that the assessment of magnesium status may be of some relevance in hypertensive subjects with cognitive disorders.

KW - Cognitive impairment

KW - Elderly

KW - Hypertension

KW - Serum magnesium

UR - http://www.scopus.com/inward/record.url?scp=0035747791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035747791&partnerID=8YFLogxK

M3 - Article

C2 - 11794635

AN - SCOPUS:0035747791

VL - 14

SP - 273

EP - 282

JO - Magnesium Research

JF - Magnesium Research

SN - 0953-1424

IS - 4

ER -